- Home
- VRAX vs GXAI Comparison
VRAX vs GXAI Comparison
Compare VRAX & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRAX | GXAI |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 8.8M |
| IPO Year | 2022 | 2023 |
Fundamental Metrics
Financial Performance| Metric | VRAX | GXAI |
|---|---|---|
| Price | $0.39 | $1.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 15.4M | 88.1K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,986.00 | ★ $694,278.00 |
| Revenue This Year | $217,274.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23205.74 |
| 52 Week Low | $0.35 | $1.00 |
| 52 Week High | $3.20 | $4.41 |
Technical Indicators
Market Signals| Indicator | VRAX | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.57 | 34.98 |
| Support Level | $0.39 | $1.07 |
| Resistance Level | $0.43 | $1.30 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 1.23 | 8.00 |
Price Performance
Historical ComparisonAbout VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.